For the year ending 2025-12-31, CLS had $172,300K increase in cash & cash equivalents over the period. $458,300K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net earnings | 832,500 |
| Depreciation and amortization | 175,700 |
| Sbc | 69,800 |
| Total return swap (trs) fair value adjustments | 253,000 |
| Restructuring and other charges | 7,300 |
| Unrealized losses on hedge derivatives | -4,700 |
| Deferred income taxes | -68,400 |
| Other | -3,000 |
| Accounts receivable | 569,100 |
| Inventories | 427,400 |
| Other current assets | 25,100 |
| Accounts payable, accrued and other current liabilities, provisions and income taxes payable | 909,500 |
| Net cash provided by operating activities | 659,500 |
| Cash paid for business acquisition, net of cash required | 0 |
| Purchase of property, plant and equipment | 201,200 |
| Proceeds from sale of assets | 0 |
| Other | 2,500 |
| Net cash used in investing activities | -203,700 |
| Borrowings under revolving loans | 500,000 |
| Repayments under revolving loans | 500,000 |
| Borrowing under term loans | 0 |
| Repayments under term loans | 17,500 |
| Principal payments of finance leases | 11,500 |
| Proceeds from issuance of capital stock | 300 |
| Repurchase of capital stock for cancellation | 153,400 |
| Purchase of treasury stock for sbc plans | 221,600 |
| Proceeds from trs settlement | 345,200 |
| Sbc cash settlement | 224,800 |
| Debt issuance costs paid | 200 |
| Net cash used in financing activities | -283,500 |
| Net increase (decrease) in cash and cash equivalents | 172,300 |
| Cash and cash equivalents, beginning of year | 423,300 |
| Cash and cash equivalents, end of year | 595,600 |
CELESTICA INC (CLS)
CELESTICA INC (CLS)